Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 26

    1.

    Calorie Restriction and Dwarf Mice in Gerontological Research.

    McKee Alderman J, Depetrillo MA, Gluesenkamp AM, Hartley AC, Verhoff SV, Zavodni KL, Combs TP.

    Gerontology. 2009 Aug 19. [Epub ahead of print]PMID: 19690401 [PubMed - as supplied by publisher]Related articles

    2.

    Lipopolysaccharide inhibition of glucose production through the Toll-like receptor-4, myeloid differentiation factor 88, and nuclear factor kappa b pathway.

    Raetzsch CF, Brooks NL, Alderman JM, Moore KS, Hosick PA, Klebanov S, Akira S, Bear JE, Baldwin AS, Mackman N, Combs TP.

    Hepatology. 2009 Aug;50(2):592-600.PMID: 19492426 [PubMed - indexed for MEDLINE]Related articles

    3.

    Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice.

    Alderman JM, Flurkey K, Brooks NL, Naik SB, Gutierrez JM, Srinivas U, Ziara KB, Jing L, Boysen G, Bronson R, Klebanov S, Chen X, Swenberg JA, Stridsberg M, Parker CE, Harrison DE, Combs TP.

    Exp Gerontol. 2009 Jan-Feb;44(1-2):26-33. Epub 2008 Jun 7.PMID: 18582556 [PubMed - indexed for MEDLINE]Related articles

    4.

    Mice deficient in mitochondrial glycerol-3-phosphate acyltransferase-1 have diminished myocardial triacylglycerol accumulation during lipogenic diet and altered phospholipid fatty acid composition.

    Lewin TM, de Jong H, Schwerbrock NJ, Hammond LE, Watkins SM, Combs TP, Coleman RA.

    Biochim Biophys Acta. 2008 Jun-Jul;1781(6-7):352-8. Epub 2008 May 15.PMID: 18522808 [PubMed - indexed for MEDLINE]Related articles

    5.

    Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity.

    Cernkovich ER, Deng J, Bond MC, Combs TP, Harp JB.

    Endocrinology. 2008 Apr;149(4):1581-90. Epub 2007 Dec 20.PMID: 18096662 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Low utilization of circulating glucose after food withdrawal in Snell dwarf mice.

    Brooks NL, Trent CM, Raetzsch CF, Flurkey K, Boysen G, Perfetti MT, Jeong YC, Klebanov S, Patel KB, Khodush VR, Kupper LL, Carling D, Swenberg JA, Harrison DE, Combs TP.

    J Biol Chem. 2007 Nov 30;282(48):35069-77. Epub 2007 Sep 28.PMID: 17905742 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Reduced adiposity in ob/ob mice following total body irradiation and bone marrow transplantation.

    Ablamunits V, Weisberg SP, Lemieux JE, Combs TP, Klebanov S.

    Obesity (Silver Spring). 2007 Jun;15(6):1419-29.PMID: 17557979 [PubMed - indexed for MEDLINE]Related articles

    8.

    Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?

    Brooks NL, Moore KS, Clark RD, Perfetti MT, Trent CM, Combs TP.

    Diabetes Obes Metab. 2007 May;9(3):246-58. Review.PMID: 17391150 [PubMed - indexed for MEDLINE]Related articles

    9.

    Identification of covalent modifications in P450 2E1 by 1,2-epoxy-3-butene in vitro.

    Boysen G, Scarlett CO, Temple B, Combs TP, Brooks NL, Borchers CH, Swenberg JA.

    Chem Biol Interact. 2007 Mar 20;166(1-3):170-5. Epub 2007 Jan 17.PMID: 17298833 [PubMed - indexed for MEDLINE]Related articles

    10.

    Fat apoptosis through targeted activation of caspase 8: a new mouse model of inducible and reversible lipoatrophy.

    Pajvani UB, Trujillo ME, Combs TP, Iyengar P, Jelicks L, Roth KA, Kitsis RN, Scherer PE.

    Nat Med. 2005 Jul;11(7):797-803. Epub 2005 Jun 19.PMID: 15965483 [PubMed - indexed for MEDLINE]Related articles

    11.

    The adipocyte as an important target cell for Trypanosoma cruzi infection.

    Combs TP, Nagajyothi, Mukherjee S, de Almeida CJ, Jelicks LA, Schubert W, Lin Y, Jayabalan DS, Zhao D, Braunstein VL, Landskroner-Eiger S, Cordero A, Factor SM, Weiss LM, Lisanti MP, Tanowitz HB, Scherer PE.

    J Biol Chem. 2005 Jun 24;280(25):24085-94. Epub 2005 Apr 18.PMID: 15843370 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle.

    Capozza F, Combs TP, Cohen AW, Cho YR, Park SY, Schubert W, Williams TM, Brasaemle DL, Jelicks LA, Scherer PE, Kim JK, Lisanti MP.

    Am J Physiol Cell Physiol. 2005 Jun;288(6):C1317-31. Epub 2005 Feb 2.PMID: 15689413 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species.

    Lin Y, Berg AH, Iyengar P, Lam TK, Giacca A, Combs TP, Rajala MW, Du X, Rollman B, Li W, Hawkins M, Barzilai N, Rhodes CJ, Fantus IG, Brownlee M, Scherer PE.

    J Biol Chem. 2005 Feb 11;280(6):4617-26. Epub 2004 Nov 9.PMID: 15536073 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.

    Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE.

    J Biol Chem. 2004 Mar 26;279(13):12152-62. Epub 2003 Dec 29.PMID: 14699128 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Role of caveolin and caveolae in insulin signaling and diabetes.

    Cohen AW, Combs TP, Scherer PE, Lisanti MP.

    Am J Physiol Endocrinol Metab. 2003 Dec;285(6):E1151-60. Review.PMID: 14607781 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity.

    Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, Laplante M, Nawrocki AR, Rajala MW, Parlow AF, Cheeseboro L, Ding YY, Russell RG, Lindemann D, Hartley A, Baker GR, Obici S, Deshaies Y, Ludgate M, Rossetti L, Scherer PE.

    Endocrinology. 2004 Jan;145(1):367-83. Epub 2003 Oct 23.PMID: 14576179 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization.

    Iyengar P, Combs TP, Shah SJ, Gouon-Evans V, Pollard JW, Albanese C, Flanagan L, Tenniswood MP, Guha C, Lisanti MP, Pestell RG, Scherer PE.

    Oncogene. 2003 Sep 25;22(41):6408-23.PMID: 14508521 [PubMed - indexed for MEDLINE]Related articles

    18.

    Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli.

    Woodman SE, Ashton AW, Schubert W, Lee H, Williams TM, Medina FA, Wyckoff JB, Combs TP, Lisanti MP.

    Am J Pathol. 2003 Jun;162(6):2059-68.PMID: 12759260 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue.

    Cohen AW, Razani B, Wang XB, Combs TP, Williams TM, Scherer PE, Lisanti MP.

    Am J Physiol Cell Physiol. 2003 Jul;285(1):C222-35. Epub 2003 Mar 26.PMID: 12660144 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin.

    Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, Patti ME, Klein SL, Weinstein RS, Scherer PE.

    Diabetes. 2003 Feb;52(2):268-76.PMID: 12540596 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity.

    Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, Engel J, Brownlee M, Scherer PE.

    J Biol Chem. 2003 Mar 14;278(11):9073-85. Epub 2002 Dec 20.PMID: 12496257 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization.

    Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, Tanen M, Berg AH, O'Rahilly S, Savage DB, Chatterjee K, Weiss S, Larson PJ, Gottesdiener KM, Gertz BJ, Charron MJ, Scherer PE, Moller DE.

    Endocrinology. 2002 Mar;143(3):998-1007.PMID: 11861525 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.

    Berg AH, Combs TP, Scherer PE.

    Trends Endocrinol Metab. 2002 Mar;13(2):84-9. Review.PMID: 11854024 [PubMed - indexed for MEDLINE]Related articles

    24.

    Endogenous glucose production is inhibited by the adipose-derived protein Acrp30.

    Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L.

    J Clin Invest. 2001 Dec;108(12):1875-81.PMID: 11748271 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.

    Razani B, Combs TP, Wang XB, Frank PG, Park DS, Russell RG, Li M, Tang B, Jelicks LA, Scherer PE, Lisanti MP.

    J Biol Chem. 2002 Mar 8;277(10):8635-47. Epub 2001 Dec 5.PMID: 11739396 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.

    Berg AH, Combs TP, Du X, Brownlee M, Scherer PE.

    Nat Med. 2001 Aug;7(8):947-53.PMID: 11479628 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...